Efficacy and safety of different modalities in the treatment of seborrheic keratosis

Not Applicable

Recruiting

• Conditions: seborrheic keratosis.; Seborrheic keratosis

• Registration Number: IRCT20141228020468N5
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Age 35 to 85
All participants should have at least 4 seborrheic keratoses with similar size and thickness on face

Exclusion Criteria

History of keloid
History of coagulopathy or anticoagulant treatment
Uncontrolled diabetes
Uncontrolled hypertension
Active infection on face
Non-compliance with treatment and follow ups
History of autoimmune connective tissue disease
Known allergy to lidocaine or tetracaine
Cold intolerance
Cryoglobulinemia
Cold urticaria and any kind of cold rash

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The rate of recovery of seborrheic keratosis. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Photography before procedure and in follow up intervals, patient satisfaction.

Secondary Outcome Measures

Name	Time	Method
Pain. Timepoint: Immediately after the intervention and 2, 8 weeks after the intervention. Method of measurement: Asking the patients.;Dyspigmentation. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Scar. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Keloid formation. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Infection. Timepoint: 2, 8 weeks after the intervention. Method of measurement: Asking the patients.